Hispidulin: A novel natural compound with therapeutic potential against human cancers

Hispidulin: A novel natural compound with therapeutic potential against human cancers

Cancer is one of the most devastating disease and leading cause of death worldwide. The conventional anticancer drugs are monotarget, toxic, expensive and suffer from drug resistance. Development of multi‐targeted drugs from natural products has emerged as a new paradigm to overcome aforementioned c...

Full description

Saved in:
Bibliographic Details
Published in:Phytotherapy research Vol. 35; no. 2; pp. 771 - 789
Main Authors: Ashaq, Aisha, Maqbool, Muhammad F., Maryam, Amara, Khan, Muhammad, Shakir, Hafiz A., Irfan, Muhammad, Qazi, Javed I., Li, Yongming, Ma, Tonghui
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Ltd 01-02-2021
Wiley Subscription Services, Inc
Subjects:
Angiogenesis
Animals
anticancer mechanism
Anticancer properties
Antineoplastic drugs
Antitumor activity
Antitumor agents
Apoptosis
Biological activity
Biological Products - pharmacology
Biological Products - therapeutic use
Cancer
Cell cycle
cell signaling
Chemical compounds
chemo‐sensitization
Clinical trials
Drug development
Drug resistance
Drugs
Flavones - pharmacology
Flavones - therapeutic use
hispidulin
Humans
Inflammation
Metastases
Mice
Natural products
Neoplasms - drug therapy
Pharmacology
Sensitizing
hispidulin
apoptosis
cell signaling
chemo-sensitization
anticancer mechanism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is one of the most devastating disease and leading cause of death worldwide. The conventional anticancer drugs are monotarget, toxic, expensive and suffer from drug resistance. Development of multi‐targeted drugs from natural products has emerged as a new paradigm to overcome aforementioned conventionally encountered obstacles. Hispidulin (HIS), is a biologically active natural flavone with versatile biological and pharmacological activities. The anticancer, antimutagenic, antioxidative and anti‐inflammatory properties of HIS have been reported. The aim of this review is to summarize the findings of several studies over the last few decades on the anticancer activity of HIS published in various databases including PubMed, Google Scholar, and Scopus. HIS has been shown to reduce the growth of cancer cells by inducing apoptosis, arresting cell cycle, inhibiting angiogenesis, invasion and metastasis via modulating multiple signaling pathways implicated in cancer initiation and progression. Multitargeted anticancer activity of HIS remains the strongest point for developing it into potential anticancer drug. We also highlighted the natural sources, anticancer mechanism, cellular targets, and chemo‐sensitizing potential of HIS. This review will provide bases for design and conduct of further pre‐clinical and clinical trials to develop HIS into a lead structure for future anticancer therapy.
Bibliography:Aisha Ashaq and Muhammad F. Maqbool contributed equally to this study.
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.6862